SpringWorks Therapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) Transcript
All right. Hello, and welcome. My name is Michael Schmidt. I am a biotech analyst with Guggenheim, and it is my great pleasure to welcome the next company, SpringWorks Therapeutics. With us today, we have Saqib Islam, the Chief Executive Officer; as well as Badreddin Edris, COO. Welcome, and thanks for joining us.
I'm delighted to be here. Thank you, Michael.
I think, Saqib, will start with some opening remarks and then we will dive into Q&A.
Great. Thank you, Michael. Thanks to you and the Guggenheim team for hosting us today.
Let me give a brief overview of our Company for those who are new to the SpringWorks story. We are a clinical-stage targeted oncology company focused on helping patients suffering from devastating cancers to live longer, better lives. We have
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
